Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T18:05:36.895Z.
Consensus retrieved: 2026-10-06T08:28:39.904Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T18:05:36.895Z.
Quote observation: 2026-10-06T18:04:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a4d4a138dd8434a7100af030d95cbc2d10a06a8c2908319c26333cf652cdf112
Forward PE Ratio (N/A) = Dated Quote Price ($6.11) / Consensus Forward EPS ($-6.49)
FORWARD PE RATIO
N/A
Aethlon Medical, Inc.
Market Cap
$3.22M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Aethlon Medical, Inc. (AEMD) | $3.22M | N/A |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.25M | N/A |
| MBody AI Ltd. (MBAI)vs › | $3.16M | N/A |
| IceCure Medical Ltd (ICCM)vs › | $3.11M | N/A |
| Moolec Science S.A. (MLEC)vs › | $3.46M | N/A |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.48M | N/A |
| Revelation Biosciences, Inc. (REVB)vs › | $3.05M | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.04M | N/A |
| Nexalin Technology, Inc. (NXL)vs › | $3.51M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2027-03-31
At the dated quote price of $6.11, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2027-03-31 | $-6.49 | $-11.93 – $-1.04 | 2 | n/m |
| 2028-03-31 | $-1.91 | $-1.91 – $-1.91 | 1 | n/m |
| 2029-03-31 | $-0.69 | $-0.69 – $-0.69 | 1 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
